Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ben Greenfield 28 September 2013. Epidemiology 1% of the population in North America More common in the Caucasian population, very rare in Asian and African.

Similar presentations


Presentation on theme: "Ben Greenfield 28 September 2013. Epidemiology 1% of the population in North America More common in the Caucasian population, very rare in Asian and African."— Presentation transcript:

1 Ben Greenfield 28 September 2013

2 Epidemiology 1% of the population in North America More common in the Caucasian population, very rare in Asian and African populations More common in females Most often presents from 9-18 months, but may present any time

3 Pathophysiology Autoimmune response against tissue transglutaminase (tTG) Gluten triggers the autoimmune response Associated with HLA DQ-2 gene (or DQ-8 sometimes) Small intestine is most affected Mucosal layer is affected Lymphocystosis within epithelial cells, hyperplasia of crypts, and atrophy/blunting of villi is observed

4 Presentation Commonly presents with diarrhea, vomiting, abdominal pain +/- abdominal distention Can present with more severe symptoms secondary to malnutrition such as weakness due to muscle wasting or lethargy. Can be “silent” without any manifestations.

5 Diagnosis/Findings Diagnosis First: anti-tTG, anti-endomysial antibodies (EMA) – if anti-tTG is 10x greater than normal and + EMA, biopsy may not be required for diagnosis Endoscopic biopsy (at least 4 samples) – see staging on next slide Other Possible Findings Low potassium, calcium, folate, magnesium, vitamin D, vitamin K, albumin, zinc Normal B12

6 Staging Type 0 = Pre-infiltrative stage (normal tissue) Type 1 = Infiltrative lesion (increased lymphocytes within epithelial cells) Type 2 = Hyperplastic lesion (same as type 1, but also with hyperplastic crypts) Type 3 = destructive lesion (same as type 2, but also with atrophy of villi) – there are sub-categories of a, b, and c, based on increasing severity of atrophy.

7 Management Lifelong avoidance of gluten containing foods (wheat, rye, barley) Temporary vitamin supplementation may be required Lactose avoidance until symptoms are well-controlled by gluten-free diet Monitoring for other autoimmune diseases- refer to endocrinologist as needed Steroids for severe or refractory symptoms Topical dapsone for dermatitis herpetiformis

8 Complications Lactose intolerance Malignancy – Small bowel lymphoma is highest risk; also, esophageal cancer, small bowel adenocarcinoma Anemia Miscarriage Osteomalacia, osteopenia, osteoporosis

9 References S Guandalini, C Cuffari, S Schwarz, P Vallee, J Vargas. “Pediatric Celiac Disease.” Medscape. 18 April 2013. Web. 28 September 2013. Murphy S, Walker A. “Celiac Disease” Pediatrics in Review 1991;12;325-330. Web. 24 September 2013


Download ppt "Ben Greenfield 28 September 2013. Epidemiology 1% of the population in North America More common in the Caucasian population, very rare in Asian and African."

Similar presentations


Ads by Google